Mass-Tort Treatment Sought for Suits Over Ortho-McNeil Antibiotic Levaquin May 13, 2009
Middlesex County, by contrast, has seven mass torts: asbestos, Ciba-Geigy environmental contamination, Gadolinium contrast agents, hormone replacement therapy, Ortho Evra, Risperdal/Seroquel/Zyprexa and Zometa/Aredia. Bergen County has four, over Depo-Provera, Digitek, NuvaRing and a toxic dump site in Mahwah. (Law.com)
J&J Agrees to Settle Evra Lawsuits in Ontario, Quebec, British Columbia Feb 28, 2009
7 million to resolve U.S. lawsuits filed by women who suffered blood clots, heart attacks or strokes after using the Ortho Evra birth-control patch, agreed to settle similar claims in three Canadian provinces. the worlds largest maker of health-care products, avoided trials through the confidential settlements in the U.S. and took the same approach in Canada with 22 plaintiffs in Ontario, British Columbia and Quebec. (Bloomberg -- Canada)
Peter Burg Appointed as Co-Chair of the Plaintiffs' Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi-District Litigation Mar 28, 2008
The PSC reports directly to Judge Polster, and is responsible for conducting pre-trial proceedings on behalf of all plaintiffs who have cases in the MDL. When asked to comment, Peter Burg said: "I am honored to receive this prestigious appointment and have the opportunity to serve as the Co-Chair of the Plaintiffs' Steering Committee and the Executive Committee in this important MDL proceeding. I take this responsibility seriously, and will work closely with the other lawyers on the PSC in... (PR Newswire)
Birth Control Patch Under Fire Mar 25, 2008
Sloan believes the birth control patch Ortho Evra caused that blood clot ... And now she's one of thousands of American women suing Johnson and Johnson, the makers of Ortho Evra ... The company says risks for Ortho Evra are spelled out on the label and that patients should make sure to read it. (NBC 11, CA)
Review Compares Latest Birth Control Options Feb 1, 2008
The Ortho Evra contraceptive patch is the only patch approved for use to date. The NuvaRing, which Organon manufactures, releases hormones into the vaginal cavity. (Science Daily)
More links between birth-control patch and blood-clot risk Jan 23, 2008
It's the second study in less than two years that found women using the Ortho Evra patch - marketed as Evra in Canada - face increased risks for developing blood clots, and is raising new concerns about the potential dangers of this contraceptive method. The U.S. Food and Drug Administration announced last Friday that the transdermal birth-control patch will carry an updated label warning women about the potential risks, the second time a warning has been issued for the product. (Globe and Mail)
Keep Love Alive Jan 22, 2008
The FDA is requiring that the results of the investigation be added to the Ortho Evra Contraceptive Transdermal Patch label since these clots could lead to a lung embolism. Supposed new HIV not even an STD. Earlier this month, researchers at the University of California San Francisco inaccurately announced that gay men were many times more likely than others to acquire MRSA USA300, a new strain of a drug-resistant, fast-spreading and potentially lethal bacteria. (Fox News)
Contraceptive patch gets new warning Jan 19, 2008
The possibility of blood clots was first placed on the Ortho Evra label in September 2006. The agency said the label on the Ortho Evra Contraceptive Transdermal Patch will include the results of a study in women aged 15-44 indicating a higher risk of clots than for women using birth control pills ... The possibility of blood clots was first placed on the Ortho Evra label in September 2006. (CNN)
Most TV Prescription Drug Ads Minimize Risk Information, Study Finds Jan 5, 2008
Macias said most ads could clearly do more to educate consumers, and points to recent advertisements for Johnson and Johnson s Ortho Evra birth control patch that give equal emphasis to the risks and benefits of the drug as an example of a more balanced approach. A prescription drug is something that consumers should be making a rational decision about, Macias said. (Science Daily)
Ohio Supreme Court: Law Limiting Damages for Pain and Suffering Is Constitutional Dec 28, 2007
Attorneys representing injured people and companies that support the concept of caps have followed the lawsuit filed by Melisa Arbino, a Cincinnati property manager, over the Ortho Evra Birth Control Patch made by New Brunswick, N.J.-based Johnson on. She contended the product caused her permanent physical damage and threatened her ability to have children, and her lawyer argued that limits on damages were unconstitutional. (Law.com)
Peterson & Associates Announces Important Notice to Defibrillator Patients Nov 12, 2007
The Firm is currently evaluating claims for clients injured by many dangerous pharmaceuticals and medical devices, such as users of the birth control patch Ortho Evra who suffered a heart attack, stroke, deep vein thrombosis, or pulmonary embolism, individuals who developed adverse reactions from either Ketek or Tequin, people developing Stevens Johnson Syndrome (SJS) or Primary Pulmonary Hypertension (PPH), those who suffered a heart attack while on Avandia, individuals who received recalled... (Primezone Releases)
The Rising Cost of College Contraception Sep 21, 2007
Roth has stopped selling the Ortho Evra skin patch all together since its new monthly price of over $50 wiped out demand. Universities have seen this problem coming since the bill was signed in January of 2006. (Utne.com)
Birth control suddenly grows too expensive for some Sep 20, 2007
Popular birth control options that don't have generic alternatives, like the NuvaRing or the Ortho Evra patch, are particularly out of reach. Some providers worry that the lack of affordable birth control will lead women to skip it or use a method they are less comfortable with, leading to unwanted pregnancies. (Anchorage Daily News)
Contraceptives see price rise Sep 11, 2007
"Now, Ortho Tri-Cyclen Lo is up to $50 a pack, and ORTHO EVRA Patch is at $50 for 3 patches.". Students who previously purchased their prescriptions at UHS are now going elsewhere for their birth control. (Daily Collegian, PA)
Estrogen May Protect Against Dementia Aug 30, 2007
LA JOLLA, CA - SEPTEMBER 12: Becca Dillur models an Ortho Evra contraceptive patch September 12, 2003 at the Association of Reproductive Health Professional convention in La Jolla, California. The Ortho Evra is a weekly contraceptive patch that slowly releases Estrogen into the body through the skin. (TIME)
Dangers of drug patches overlooked Aug 27, 2007
Sales of Ortho Evra, the first birth-control patch, plunged last year after the FDA cautioned that it exposed women to higher levels of a hormone linked to dangerous blood clots than do oral contraceptives. With pills, the drug level spikes after consumption, dropping as the time for the next dose approaches. (Los Angeles Times)
The College "Hook-up" Culture May 23, 2007
The Food and Drug Administration said it has updated the label on the Ortho Evra birth-control patch to reflect the results of one study that found women using the patch faced twice the risk of blood clots than did women on the pill. (AP Photo/Johnson on). (Townhall.com)
Death, Lawsuits, and the Pill Mar 6, 2007
It seems so easy and modern to take a small pill every day, or to get a shot or implant like Depo Provera or Norplant, or even to wear a patch like the Ortho Evra ... The Ortho Evra birth control patch has been linked to 23 deaths, including a 17 year old who died of a pulmonary embolism, which is a condition usually found in senior citizens ... Young people contracted these illnesses because they used hormonal methods like Ortho Evra, which put chemicals called progestins in the body. (Suite101.com)
New cervical cancer vaccine should not be mandatory for teens Feb 28, 2007
Although the FDA approved the Ortho Evra birth control patch in 2001, stating that it was as safe as oral contraceptives, the patch was later found to cause death and blood clots at a rate three times higher than in women taking the pill. The FDA updated its warnings on Ortho Evra in 2005, this time stating that the patch releases 60 percent more total estrogen in a woman's blood than the typical birth control pill, which could increase the risk of blood clots. (Daily Collegian, PA)
Study: Hormone patch sa000004ADfer than pill Feb 27, 2007
The FDA recently required new warnings on one such contraceptive patch Ortho-McNeil Pharmaceutical's Ortho Evra. Also, women should tell their doctors about any other drugs, vitamins or supplements they are taking. (Atlanta Journal-Constitution)
New Worries About Birth-Control Pills Feb 3, 2007
The next-generation of hormonal birth-control methodsincluding patches such as Ortho Evra, as well as pills such as Seasonale and Ortho Tri-Cyclen Lo, typically contain lower levels of hormones than the versions developed decades ago. The reduced level of hormones in the new pills helps reduce some side effects, but it also means they are less forgiving should a woman miss a day or two. (MSNBC -- Health)
FDA Considers Birth Control Pill Standards Jan 24, 2007
Lawsuit Alleges Ortho Evra Caused Serious Illnesses, Death ... In September, for example, the FDA warned women that Johnson on's birth control patch Ortho Evra could raise their chances of developing blood clots in the legs and lungs. (CBS News)
FDA Ponders Lifting Bar for Birth Control Drugs Jan 23, 2007
In September, for example, the FDA warned women that 's birth control patch Ortho Evra could raise their chances of developing blood clots in the legs and lungs. Johnson & Johnson markets a number of traditional contraceptives, including its top-selling birth control pill, Ortho Tri-Cyclen. (Fox News)
Parker Waichman Alonso Mark, LLP Retained by Hundreds of Hurricane Katrina Victims Whose Insurance Claims Have Been Denied Jan 12, 2007
In addition to representing victims of bad faith insurance denials, Parker & Waichman, LLP represents thousands of individuals injured by Guidant Defibrillators, Drug Coated Coronary Stents, Vioxx, Fosamax, Ketek, ReNu with MoistureLoc, Ortho Evra and many other defective drugs and medical products. For more information on Parker Waichman Alonso Mark LLP, please visit: or call (800) LAW-INFO.. (Primezone Releases)